Shoulder joint

First shoulder arthroplasty surgeries using Stryker’s Blueprint® Mixed Reality Guidance System completed in Europe

Retrieved on: 
Wednesday, February 28, 2024
Software, Hardware, Surgery, General Health, Health, Medical Devices, Health Technology, Technology, Hospital, Doctor of Philosophy, Multimedia, MD, Shoulder joint, Surgeon, Blueprint, HoloLens 2, SYK, Safety, Patient, Anatomy, Orientation, Microsoft, Dentistry

View the full release here: https://www.businesswire.com/news/home/20240227354011/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240227354011/en/
    Stryker's Blueprint Mixed Reality Guidance System offers shoulder arthroplasty surgeons a new tool to execute their pre-operative plan.
  • (Photo: Business Wire)
    “It’s exciting to be one of the first two hospitals in Europe to use Stryker’s Mixed Reality Guidance System,” said Professor Berhouet.
  • Blueprint Mixed Reality Guidance System allows surgeons and their instruments to be ‘guided’ by 3D images and guidance widgets, which can be displayed on the patient and in the surgeon’s line of sight without disrupting normal workflow.
  • The MR Guidance system received a CE mark at the end of 2023 and the first surgeries globally were performed in the U.S. and Canada in December 2023.

Hyperice Expands Contrast Therapy Lineup with Hyperice X Shoulder

Retrieved on: 
Tuesday, October 3, 2023
Mobile, Wireless, Sports, Lifestyle, Consumer, Apps, Applications, Medical Devices, Technology, Other Sports, Health Technology, Fitness & Nutrition, Other Technology, Health, NP-hardness, Shoulder, Cuff, Tears, Quality of life, Multimedia, Temperature, Shoulder joint, Pain, Athlete, Motion, Patient, Best Buy, Swelling, MLB, Chronic pain, Tendon, Medical imaging

Hyperice, a global high-performance wellness brand, today announced the latest innovation to its contrast therapy product lineup, the Hyperice X Shoulder .

Key Points: 
  • Hyperice, a global high-performance wellness brand, today announced the latest innovation to its contrast therapy product lineup, the Hyperice X Shoulder .
  • By way of contrast therapy, a scientifically proven method designed to reduce pain and swelling and improve range of motion, the Hyperice X Shoulder combines science, technology, and innovation to treat a plethora of common shoulder issues while also enhancing users' regular warmups and cool-downs.
  • In 2022 alone, shoulder injuries accounted for more than 30% of all sports-related injuries , and the Hyperice X Shoulder helps users regain shoulder mobility, provides pain relief, and restores quality of life.
  • View the full release here: https://www.businesswire.com/news/home/20231003887143/en/
    MLB All-Star Fernando Tatís Jr. with the new Hyperice X Shoulder (Photo: Business Wire)
    “The mission of Hyperice is to help everyone on Earth move better, and with our Hyperice X technology now extended to the shoulder, we're delivering more solutions to those who need it most," said Jim Huether, CEO of Hyperice.

Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results

Retrieved on: 
Monday, September 11, 2023
Workforce, Heart, Insurance, Osteoarthritis, Maintenance, Drug development, Shoulder, Synovial fluid, Hospital, Drainage, Clinical trial, Absorption, Inflammation, Immunotherapy, Sepsis, Shoulder joint, Pain, Degenerative disease, Malignancy, Patient, Physician, Joint, Research, FDA, Therapy, Phase, Knee, Safety, Disease, Pharmaceutical industry

Results demonstrated acceptable tolerability and safety, allowing the program to proceed to assess the efficacy of AllocetraTM in solid tumor indications in combination with other therapies and at higher doses.

Key Points: 
  • Results demonstrated acceptable tolerability and safety, allowing the program to proceed to assess the efficacy of AllocetraTM in solid tumor indications in combination with other therapies and at higher doses.
  • Nes-Ziona, Israel, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company announced today a strategic reprioritization plan and its financial results for the second quarter ended June 30, 2023.
  • "Patient well-being and advancing medical science have always been at the heart of our mission," said Oren Hershkovitz, Ph.D., CEO of Enlivex.
  • As of June 30, 2023, Enlivex had cash and cash equivalents, short term bank deposits and long term interest-bearing bank deposits of approximately $36 million.

HSS Surgeon Performs World's First Implant of a Stemmed Elliptical Head Prosthesis for Anatomic Shoulder Replacement

Retrieved on: 
Tuesday, June 27, 2023
Infection, Osteoarthritis, Elbow, Surgeon, Shoulder, Elective surgery, Arthritis, Anatomy, Shoulder joint, U.S. News & World Report, Hospital for Special Surgery, Motion, MD, Patient, Rheumatology, HSS, Hospital, Humerus, News, Dentistry, Nursing

NEW YORK, June 27, 2023 /PRNewswire/ -- Theodore A. Blaine, MD, a shoulder and elbow surgeon at Hospital for Special Surgery (HSS), has performed the world's first implantations of a stemmed elliptical head prosthesis for anatomic shoulder replacement surgery. The breakthrough procedure provides the most anatomic solution for patients with arthritis, and was performed in May at HSS in Stamford, CT. HSS has a collaborative relationship with Stamford Health.

Key Points: 
  • NEW YORK, June 27, 2023 /PRNewswire/ -- Theodore A. Blaine, MD , a shoulder and elbow surgeon at Hospital for Special Surgery (HSS), has performed the world's first implantations of a stemmed elliptical head prosthesis for anatomic shoulder replacement surgery.
  • The stemmed elliptical head enables surgeons to readily convert an anatomic total shoulder replacement prosthesis to a reverse shoulder replacement prosthesis, should a revision surgery ever be needed in the future.
  • Dr. Blaine is the first surgeon in the world to use this advanced technology, placing an elliptical head on a stemmed implant.
  • "The main reason for implanting a convertible prosthesis in a patient's shoulder is that an anatomic shoulder replacement provides a more normal shoulder than a reverse prosthesis in active patients.

6K Additive and Surgical Metal Recycling to Create Circular Sustainable Supply Chain for Medical Implants

Retrieved on: 
Thursday, May 4, 2023
Metal, Partnership, Life, Carbon footprint, Oxygen, Spine, Recycling, Carbon, Shoulder joint, Titanium, Organization, Plasma, SMR, K, Particle size, Alloy, Cobalt, Knee, 3D printing, Medical device

PITTSBURGH, May 4, 2023 /PRNewswire/ -- 6K Additive, a division of 6K Inc., announced today that it has entered into an agreement with Australia-based Surgical Metal Recycling Pty Ltd (SMR). The companies will explore a shared mission to transform the metals supply chain in Australia, including revolutionizing the way surgical implants are treated at the end of their useful life.

Key Points: 
  • PITTSBURGH, May 4, 2023 /PRNewswire/ -- 6K Additive , a division of 6K Inc., announced today that it has entered into an agreement with Australia-based Surgical Metal Recycling Pty Ltd (SMR).
  • The companies will explore a shared mission to transform the metals supply chain in Australia, including revolutionizing the way surgical implants are treated at the end of their useful life.
  • The resulting premium powders can then be used to create new parts through additive manufacturing, with the ultimate goal of the partnership to create new certified implants from existing parts through a sustainable and circular supply chain.
  • Being able to source feedstock and recycle medical implants is the first innovative step toward our mission," said Frank Roberts, President of 6K Additive.

6K Additive and Surgical Metal Recycling to Create Circular Sustainable Supply Chain for Medical Implants

Retrieved on: 
Thursday, May 4, 2023
Metal, Partnership, Life, Carbon footprint, Oxygen, Spine, Recycling, Carbon, Shoulder joint, Titanium, Organization, Plasma, SMR, K, Particle size, Alloy, Cobalt, Knee, 3D printing, Medical device

PITTSBURGH, May 4, 2023 /PRNewswire/ -- 6K Additive, a division of 6K Inc., announced today that it has entered into an agreement with Australia-based Surgical Metal Recycling Pty Ltd (SMR). The companies will explore a shared mission to transform the metals supply chain in Australia, including revolutionizing the way surgical implants are treated at the end of their useful life.

Key Points: 
  • PITTSBURGH, May 4, 2023 /PRNewswire/ -- 6K Additive , a division of 6K Inc., announced today that it has entered into an agreement with Australia-based Surgical Metal Recycling Pty Ltd (SMR).
  • The companies will explore a shared mission to transform the metals supply chain in Australia, including revolutionizing the way surgical implants are treated at the end of their useful life.
  • The resulting premium powders can then be used to create new parts through additive manufacturing, with the ultimate goal of the partnership to create new certified implants from existing parts through a sustainable and circular supply chain.
  • Being able to source feedstock and recycle medical implants is the first innovative step toward our mission," said Frank Roberts, President of 6K Additive.

What are dead hangs? What are the shoulder pain risks and how do I do them safely?

Retrieved on: 
Friday, April 21, 2023
People, Exercise, Elasticity, Shoulder, Ligament, Rotation, Humerus, Watson, Hypermobility, Brain, Female, Shoulder joint, Science, Dislocation, Motion, Patient, Risk, Biology, Joint, Program, Ageing, Health, Hand, Human, Cabinetry, Road, Sports equipment

The goal is usually to improve upper-body strength and shoulder stability, or stretch out muscles around the shoulder.

Key Points: 
  • The goal is usually to improve upper-body strength and shoulder stability, or stretch out muscles around the shoulder.
  • Are dead hangs good for shoulder health?
  • It really depends on your reason for doing it, your individual biology, and how you do them.

The shoulder: a relatively unstable joint

    • But while dead hangs may be OK for people with good upper-body strength and no shoulder problems, they can be risky for others.
    • The shoulder, by design, is a relatively unstable joint.
    • It has a large ball-type bone called a humerus, which sits in a relatively small socket called a glenoid.

Hypermobility and the shoulder

    • This is called hypermobility and may be in the shoulder or all joints.
    • People with shoulder hypermobility are more likely to develop painful shoulder instability, which is when the ball often pops out of the socket.
    • Shoulder instability is associated with reduced strength and coordination in the shoulder muscles.

What can I do instead of dead hangs?

    • A treatment known as the Watson Instability Program has had good results for resolving non-traumatic shoulder instability when compared to a general shoulder strength program.
    • It involves recruiting the shoulder blade and shoulder joint muscles to improve the contact between the ball and the socket.
    • Building shoulder blade control and strength can help boost broader shoulder strength.

Still keen to try dead hangs?


    If you are determined to do dead hangs, remember to:
    • We are investigating brain changes in patients with multidirectional instability of the shoulder.
    • Charlotte Ganderton receives funding from Arthritis Australia, Physiotherapy Research Foundation, Swinburne University of Technology, National Institute of Circus Arts and La Trobe University.

Emory Healthcare Researcher Wins Two Awards Using Konica Minolta’s AI Analysis Tool With Dynamic Digital Radiography in Shoulder Pathology

Retrieved on: 
Friday, October 14, 2022
Physician, LinkedIn, Master of Science, Assistant, Diagnosis, Science, National, ICC, Patient, Konica Minolta, Research, Twitter, Adhesive capsulitis of the shoulder, Publication, Intelligence, SHR, Technology, Knowledge, Goal, Emory Healthcare, Scapula, MD, DRS, Doctor of Philosophy, Ascending limb of loop of Henle, Pathology, AI, Motion, Health, Innovation, Radiography, The Foundation for Young Australians, GLOBE, Shoulder joint, Clinical research, Shoulder, DDR, Solution, Engineering, Algorithm, Medicine, Medical imaging, Medical device, Facebook

Dr. Hussains research evaluated a prototype artificial intelligence (AI) tool developed by Konica Minolta Healthcare for characterizing shoulder dynamics.

Key Points: 
  • Dr. Hussains research evaluated a prototype artificial intelligence (AI) tool developed by Konica Minolta Healthcare for characterizing shoulder dynamics.
  • Seventy-three shoulders (23 normal controls, 41 rotator cuff tears and nine adhesive capsulitis) were imaged using Dynamic Digital Radiography (DDR) and reviewed by two trained readers.
  • With the DDR image data, Dr. Hussain was able to visualize changes in shoulder pathology and, using the proof-of-concept AI tool, acquire measurements to calculate the scapulohumeral rhythm (SHR).
  • The new AI tool employs a machine learning algorithm utilizing a convolutional neural network architecture to automate this analysis.

Innocoll and DURECT Announce U.S. launch of POSIMIR®

Retrieved on: 
Monday, September 26, 2022
Central nervous system, Injection, Safety, Bradycardia, Achievement, Patient, U.S. Securities and Exchange Commission, Bupivacaine, Technology, C-reactive protein, Pain management, Annual report, Headache, AH, Risk, Fatty liver disease, COVID-19, Respiratory arrest, Methemoglobinemia, Sale, Food, Diarrhea, Vomiting, Anesthetic, Bruise, Surgeon, DNA, Nausea, SEC, Patent, Dizziness, Allergy, Coma, FDA, NASH, Association, Shoulder joint, Tinnitus, Paresthesia, Form 10-K, Chondrolysis, United States patent law, Somnolence, SABER, Constipation, Marketing, Itch, Blood, Incidence, Hypersensitivity, Elective surgery, Private Securities Litigation Reform Act, Regulation of tobacco by the U.S. Food and Drug Administration, Chronic liver disease, CNS, Anemia, Dentistry, Pharmaceutical industry, Vaccine, Fever, Dysuria, Dysgeusia, Hypoesthesia

"We are excited to bring a potential cornerstone of multi-modal post-operative pain management to surgeons with the launch of POSIMIR," said Louis Pascarella, Chief Executive Officer of Innocoll.

Key Points: 
  • "We are excited to bring a potential cornerstone of multi-modal post-operative pain management to surgeons with the launch of POSIMIR," said Louis Pascarella, Chief Executive Officer of Innocoll.
  • Per the terms of the collaboration between Innocoll and DURECT, Innocoll will make a $2 million payment to DURECT triggered by the first commercial sale of POSIMIR.
  • Previously, in August 2022, DURECT was issued a new patent by the US Patent Office, extending US patent coverage of POSIMIR to at least 2041, resulting in an $8 million milestone payment by Innocoll to DURECT.
  • NOTE: POSIMIR is a trademark of Innocoll Pharmaceuticals Limited in the U.S. and a trademark of DURECT Corporation outside of the U.S. SABER is a trademark of DURECT Corporation.

Movmedix Reports 60% Global Growth, and Positions Itself as the Leader in the Artificial Ligament Market

Retrieved on: 
Tuesday, February 8, 2022
Health, Sports, Medical Devices, Hospitals, Surgery, General Sports, Biotechnology, Pain, Trial of the century, LARS, Growth, Biomimetics, Rehabilitation, Knee, Marketing, Shoulder, PIA, Risk, Patient, Injury, Hospital, Bioresorbable stent, Competition (economics), Workforce, Laboratoires Expanscience, Ligament, Sports medicine, Shoulder joint, SME, Infection, Disease, Jordan Tourism Development Project, Athlete, Medical device

These artificial ligaments are intended to replace or reinforce a natural ligament injured at the knee or shoulder joint and prevent a transplant from the tendon taken from the patient.

Key Points: 
  • These artificial ligaments are intended to replace or reinforce a natural ligament injured at the knee or shoulder joint and prevent a transplant from the tendon taken from the patient.
  • With a presence in more than 25 countries, Movmedix asserts its position as a global player in the sports medicine market.
  • 2- 5th generation Biomimetic and Bioresorbable Ligament: a ligament with a coating grafted onto a bioresorbable material to promote the growth of a new natural ligament.
  • Movmedix, a medical device company, is today the world leader in the development and manufacture of artificial ligaments.